References
- Rothova A, Schulten MSA, Treffers WF, Kilstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80:322–336.
- Jabs DA, Rosenbaum JT, Foster CS, Holland GN, Jaffe G.J, Louie JS, Nussenblatt RB, Stiehn RE, Tessler H, Van Gelder RN, Whitcup SM, Yocum D. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders. Am J Ophthalmol. 2000; 130:492–513.
- Gaudio PA. A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation. Ocul Immunol Want. 2004,xx:x3oc-yyy.
- McGhee CNE, Watson DB, Midgley JM, Noble MJ, Dutton GN, Fern AT. Penetration of synthetic corticosteroids into human aqueous humour. Eye. 1990;4:526–530.
- Foster CS, Alter G, DeBarge LR, Raizman MB, Crabb JL, Santos CI, Feiler LS, Friedlaender MH. Efficacy and safety of rimexolone i % ophthalmic suspension vs i % prednisolone acetate in the treatment of uveitis. Am J Ophthalmol. 1996;122:171–182.
- Loteprednol Etabonate US Uveitis Study Group. Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Am J Ophthalmol. 1999;127:537–544.
- Helm CJ, Holland GN. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis. Am J Ophthalmol. 1995;120:55–64.
- Hyndiuk RA, Reagan MG. Radioactive depot-corticosteroid penetration into monkey ocular tissue. Arch Ophthalmol. 1968;80:499–503.
- Hyndiuk RA. Radioactive depot-corticosteroid penetration into monkey ocular tissue. II. Subconjunctival administration. Arch Ophthalmol. 1969;82:259–263.
- Thach AB, Dugel PU, Flindall RJ, Sipperley JO, Sneed SR. A comparison of retrobulbar versus sub-tenon's corticosteroid therapy for cystoid macular edema refractory to topical, medications. Ophthalmology. 1997;104:2003–2008.
- Jabs DA. Subconjunctival corticosteroids should not be used in the treatment of scleritis. Ophthalmology. 2002;109:806–807.
- Dana MR, Merayo-Lloves Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996;103:1846–1853.
- Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet. 19871: 902–906.
- Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998;339: 292–299.
- Jabs DA, Mudun A, Dunn JP, Marsh MJ. Episcleritis and sleritis: clinical features and treatment results. Am J Ophthalmol. 2000;130:469–476.
- Antcliff RJ, Spa1ton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology. 2001;108: 765–772.
- Moshfeghi DM, Kaiser PK, Scott IU, et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2003;136:791–796.
- Jaffe GJ, Ben-Nun J, Guo H, et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107: 2024–2033.
- Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology. 1999;106:594–599.
- Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–263.
- Jabs DA, Akpek EK. Immunosuppression for posterior uveitis. Retina (in press).